Long-term survival among men with conservatively treated localized prostate cancer.
暂无分享,去创建一个
[1] N. L. Johnson,et al. Survival Models and Data Analysis , 1982 .
[2] B A Miller,et al. The role of increasing detection in the rising incidence of prostate cancer. , 1995, JAMA.
[3] R. Thisted,et al. Results of conservative management of clinically localized prostate cancer. , 1994, The New England journal of medicine.
[4] J. Beck,et al. A critique of the decision analysis for clinically localized prostate cancer. , 1994, The Journal of urology.
[5] P C Prorok,et al. Prostate Cancer Screening: What We Know and What We Need To Know , 1993, Annals of Internal Medicine.
[6] L. Holmberg,et al. High 10-year survival rate in patients with early, untreated prostatic cancer. , 1992, JAMA.
[7] J. Concato,et al. Problems of comorbidity in mortality after prostatectomy. , 1992, JAMA.
[8] R H Brook,et al. Quality-of-life outcomes in men treated for localized prostate cancer. , 1995, JAMA.
[9] E. Greenberg,et al. Changes in prostate cancer incidence and treatment in USA , 1994, The Lancet.
[10] M. Barry,et al. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team. , 1993, JAMA.
[11] M. Cowen,et al. A Markov model of the natural history of prostate cancer. , 1994, Journal of clinical epidemiology.
[12] S G Pauker,et al. Screening for prostate cancer. A decision analytic view. , 1994, JAMA.
[13] A. Feinstein,et al. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. , 1974, Journal of chronic diseases.
[14] T. Tong,et al. Cancer statistics, 1994 , 1994, CA: a cancer journal for clinicians.
[15] S Greenfield,et al. The Importance of Co-existent Disease in the Occurrence of Postoperative Complications and One-Year Recovery in Patients Undergoing Total Hip Replacement: Comorbidity and Outcomes After Hip Replacement , 1993, Medical care.
[16] W C Black,et al. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. , 1993, The New England journal of medicine.
[17] W. Catalona,et al. New staging systems for prostate cancer. , 1989, The Journal of urology.
[18] D McLerran,et al. An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team. , 1993, JAMA.
[19] D R Holtgrave,et al. The evaluation and treatment of men with asymptomatic prostate nodules in primary care: a decision analysis. , 1992, The Journal of family practice.
[20] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.